These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7414941)

  • 21. [Hodgkin's nodular paragranuloma (nodular Hodgkin's disease, with lymphocytic predominance): apropos of 29 cases].
    Molina T; Diebold J
    Bull Cancer; 1987; 74(4):463-72. PubMed ID: 3663967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intercellular substances in Hodgkin's lymphomas. Ultrastructural investigations.
    Stiller D; Katenkamp D
    Virchows Arch A Pathol Anat Histol; 1978 Oct; 380(1):81-90. PubMed ID: 152506
    [No Abstract]   [Full Text] [Related]  

  • 23. Ultrastructural comparison of Hodgkin's and non-Hodgkin's lymphomas.
    Peiper SC; Kahn LB
    Histopathology; 1982 Jan; 6(1):93-109. PubMed ID: 7056514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.
    Regula DP; Hoppe RT; Weiss LM
    N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin's disease accompanied with thymoma.
    Nemoto K; Ishikawa H; Ohnishi Y; Nakamura T; Ohsaki N
    Acta Pathol Jpn; 1987 Sep; 37(9):1505-12. PubMed ID: 3687430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
    Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
    Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The histology of the initial relapse of Hodgkin's disease.
    Colby TV; Warnke RA
    Cancer; 1980 Jan; 45(2):289-92. PubMed ID: 7351011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transmission electron microscopy in the differential diagnosis of non-Hodgkin's lymphoma using fine-needle aspirates].
    Lubiński J; Domagała W
    Patol Pol; 1988; 39(3):177-88. PubMed ID: 3247216
    [No Abstract]   [Full Text] [Related]  

  • 29. Coexistence of nodular lymphocyte predominance Hodgkin's disease and Hodgkin's disease of the usual type.
    Gelb AB; Dorfman RF; Warnke RA
    Am J Surg Pathol; 1993 Apr; 17(4):364-74. PubMed ID: 8494105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ultrastructural identification of tissue basophils and mast cells in Hodgkin's disease.
    Parmley RT; Spicer SS; Wright NJ
    Lab Invest; 1975 Apr; 32(4):469-75. PubMed ID: 1127869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lacunar cells of nodular sclerosing Hodgkin's disease: an ultrastructural and immunohistologic study.
    Anagnostou D; Parker JW; Taylor CR; Tindle BH; Lukes RJ
    Cancer; 1977 Mar; 39(3):1032-43. PubMed ID: 410494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hodgkin's disease: a clinicopathologic study of 659 cases.
    Colby TV; Hoppe RT; Warnke RA
    Cancer; 1982 May; 49(9):1848-58. PubMed ID: 7074584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain.
    Stein H; Hansmann ML; Lennert K; Brandtzaeg P; Gatter KC; Mason DY
    Am J Clin Pathol; 1986 Sep; 86(3):292-7. PubMed ID: 3529924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of fine needle aspiration cytology in nodular sclerosis variant of Hodgkin's lymphoma.
    Jogai S; Dey P; Al Jassar A; Amanguno HG; Adesina AO
    Acta Cytol; 2006; 50(5):507-12. PubMed ID: 17017435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous Hodgkin's disease: an immunohistochemical analysis.
    Cerroni L; Beham-Schmid C; Kerl H
    J Cutan Pathol; 1995 Jun; 22(3):229-35. PubMed ID: 7593816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis.
    Enblad G; Sundstrom C; Glimelius B
    Hematol Oncol; 1993; 11(4):187-93. PubMed ID: 8144133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syncytial variant of nodular sclerosing Hodgkin's disease: fine-needle aspiration findings in two cases.
    Stanley MW; Powers CN
    Diagn Cytopathol; 1997 Dec; 17(6):477-9. PubMed ID: 9407212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro sensitivity of Hodgkin's disease to hydrogen peroxide toxicity. Correlation with peroxidase activity.
    Samoszuk MK; Rietveld C; Gidanian F; Petersen A
    Cancer; 1989 Jun; 63(11):2111-4. PubMed ID: 2541883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.